What is the likelihood of passing renal stones based on size for a patient with no significant underlying medical conditions or previous stone episodes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Likelihood of Spontaneous Renal Stone Passage by Size

Stones <5 mm pass spontaneously in 68-75% of cases overall, with distal ureteral stones <5 mm achieving passage rates up to 89%, while stones ≥5 mm drop to 47-62% passage rates, and stones >10 mm rarely pass without intervention. 1, 2, 3

Size-Specific Passage Rates

Stones <5 mm

  • Overall spontaneous passage: 68-75% 1, 3
  • Distal ureteral location: 89% 1, 3
  • Mid-ureteral location: 58-70% 1
  • Upper ureteral location: 49-75% 1, 3
  • Mean time to passage: 17 days (range 6-29 days) 1

Stones 5-10 mm

  • Overall spontaneous passage: 47-62% 1, 2, 3
  • Passage rates decline significantly as size increases within this range 1
  • Research data shows more granular breakdown: 65% for 5 mm stones, 33% for 6 mm stones, and only 9% for stones ≥6.5 mm 4

Stones >10 mm

  • Spontaneous passage is unlikely and surgical intervention is typically required 2, 3, 5
  • The European Association of Urology recommends active intervention for stones >10 mm due to low spontaneous passage rates 3

Location-Based Passage Rates

Stone location significantly impacts passage probability, with distal stones having the highest success rates: 1, 4, 6

  • Distal ureteral stones: 68-83% 1
  • Mid-ureteral stones: 58-70% 1
  • Upper ureteral/renal stones: 49-52% 1

The more proximal the stone location, the lower the chance of spontaneous passage, independent of size 6

Time Course of Passage

Most stones that will pass spontaneously do so within the first 4 weeks: 1, 6

  • 55.3% pass within 7 days 6
  • 73.7% pass within 14 days 6
  • 88.5% pass within 28 days 6
  • 97.7% pass within 60 days 6

Medical Expulsive Therapy Impact

Alpha-blockers (tamsulosin 0.4 mg daily) increase passage rates by an absolute 22-29% for stones 5-10 mm: 3, 5

  • With alpha-blockers: 77-87% passage rate 3, 5
  • Without alpha-blockers: 54-61% passage rate 3, 5
  • Number needed to treat: 4-5 patients 3
  • Reduces time to expulsion by approximately 3 days 3

Clinical Decision Algorithm

Conservative Management Appropriate When:

  • Stone size ≤5 mm (75% passage rate justifies observation) 1, 3
  • Stone size 5-10 mm with distal location (consider MET to increase passage to 77%) 2, 5
  • Well-controlled pain without excessive analgesic requirements 5
  • No clinical evidence of sepsis or infection 5
  • Adequate renal functional reserve 5

Active Intervention Indicated When:

  • Stone size >10 mm (passage unlikely) 2, 3, 5
  • Failed conservative management after 4-6 weeks 3
  • Complications develop (infection, refractory pain, declining renal function) 1, 3
  • Stone growth on serial imaging 1

Important Caveats

The 6 mm threshold represents a critical decision point where passage rates drop dramatically from 65% at 5 mm to 33% at 6 mm and only 9% at 6.5 mm or larger 4. This sharp decline should inform aggressive consideration of intervention for stones approaching or exceeding 6 mm.

Renal stones have lower passage rates than ureteral stones of equivalent size because they must first enter the ureter before passage can occur 6, 7. Spontaneous passage of renal stones occurs in only 3-29% of cases 1.

Hydronephrosis presence may predict lower passage rates in specific subgroups, though stone size and location remain the dominant predictors 4, 8.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Kidney Stone Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Nonobstructing Kidney Stone Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Spontaneous Passage Rate for Ureteral Stones

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinical outcome of pediatric stone disease.

The Journal of urology, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.